LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 63854

Search options

  1. Article ; Online: Intraperitoneal hemorrhage after oophorocystectomy caused by coagulation factor XI deficiency: A case report and literature review.

    Xia, Yan / Zhang, Xiaofei

    Asian journal of surgery

    2024  

    Language English
    Publishing date 2024-01-27
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 1068461-x
    ISSN 0219-3108 ; 1015-9584
    ISSN (online) 0219-3108
    ISSN 1015-9584
    DOI 10.1016/j.asjsur.2024.01.109
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Book ; Online: DATS 6401 – Final Project – Xi Zhang

    Zhang, Xi

    2020  

    Abstract: COVID-19 SARS and Ebola Data Analysis This project aims to arouse public awareness of COVID-19 prevention and control. We hope to find out the similarities and differences between COVID-19 and other infectious diseases, so as to further understand COVID- ... ...

    Abstract COVID-19 SARS and Ebola Data Analysis This project aims to arouse public awareness of COVID-19 prevention and control. We hope to find out the similarities and differences between COVID-19 and other infectious diseases, so as to further understand COVID-19. * Publish Site: https://xzhangfox.github.io/COVID-19-SARS-and-Ebola-Data-Analysis/ Motivation When I saw COVID-19 starting to spread in Washington state in February, I am worried every day about the new coronavirus outbreak and the lack of awareness of protection in the United States. As a Chinese, I know what has happened in China in January and February. China is recovering right in March but it paid hugely. I know the reason for China's recovering was that the whole country was on high alert and everyone attached great importance to epidemic prevention. But it is happening again. The United States in March, like China at the start of the outbreak, is not taking it seriously. People didn't realize the seriousness until the death rate rose. I don’t want people to suffer again. I hope to pass on the severity of the new coronavirus and help people live safely during the outbreak. So I started this data research project on COVID-19. Through data visualization, people's awareness of self-protection is aroused, and they hope to find more directions for the solution of COVID-19 from previous outbreak cases. Requirements * Python 2.7/3.7 * Visual Studio Code * Tableau Goals Visualization I am going to visualize epidemic data mainly in Tableau. The information carried by the data will be mined from varying aspects and communicated to the audience interactively. Use HTML, CSS, javascript, and design styles to capture the audience's attention. And make the expression of professional knowledge more popular and interesting. Modeling For further research, I plan to build a model to analyze similarities and differences of COVID-19, SARS, and Ebola data. Use the time series models to predict the spread trend in the time dimension. Data Preprocessing Novel Coronavirus (COVID-19) Cases Data is collected by The Center for Systems Science and Engineering (CSSE) at JHU, and available to be downloaded to CSV files from GitHub. Due to the ongoing outbreak of novel coronavirus pneumonia. JHU CSSE updates the latest data of the day on a daily basis. I wrote a code in Python to walk through all the data files in the folder and organize them into a complete data set. With the daily update of JHU CSSE, my total data volume is increasing day by day. The latitude, longitude, and country/state data contained in this data can be used in geographic charts, and time-lines accurate to the hour can provide research on trends and future predictions. I found reliable historical data on SARS and Ebola on Kaggle. Since they are no longer updated, I only preprocessed them and unified the type of the column with COVID-19 data. They were also uploaded to the Google Spreadsheet just like the COVID-19 data. Because of the data format of the daily report, even error types are difficult to unify. I tried using pandas to collate the content and the NLP model to fetch the data I needed. But this part is still being perfected. Inspiration for Web Design I want the homepage to be as eye-catching as possible. Then, with the introduction of striking visual effects, the severity of COVID-19 was conveyed by embedding relevant literature, news, videos, and charts. In terms of the interaction method, I hope to have a certain dynamic effect, so that the whole aesthetic effect is lively. References * CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html * YouTube: https://www.youtube.com/watch?v=21MIvkk7Imc * W3School: https://www.w3school.com.cn/index.html * CDBM: https://www.cebm.net/covid-19/global-covid-19-case-fatality-rates/ * NBCNews: https://www.nbcnews.com/health/coronavirus
    Keywords covid19
    Subject code 028
    Publishing date 2020-05-05
    Publishing country eu
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Application of Indocyanine Green in Combination with Da Vinci Xi Robot in Surgeries on the Upper Urinary Tract: A Case Series Study.

    Zeng, Sheng / Xing, Shaoqiang / Xing, Wenzhou / Bai, Zhijie / Zhang, Jingyuan / Li, Yanan / Wang, Haifeng / Liu, Qian

    Journal of clinical medicine

    2023  Volume 12, Issue 5

    Abstract: ... injection through the collection system of the urinary tract for Da Vinci Xi robot navigation in complex ... with Da Vinci Xi robot navigation in the Tianjin First Central Hospital between December 2019 and October ...

    Abstract Background: To explore the application value of intraoperative imaging by indocyanine green (ICG) injection through the collection system of the urinary tract for Da Vinci Xi robot navigation in complex surgeries on the upper urinary tract.
    Methods: Data of 14 patients who underwent complex surgeries of the upper urinary tract post-ICG injection through the collection system of the urinary tract in combination with Da Vinci Xi robot navigation in the Tianjin First Central Hospital between December 2019 and October 2021 were analyzed in this retrospective study. The operation duration, estimated blood loss, and exposure time of ureteral stricture to ICG were evaluated. The renal functions and tumor relapse were evaluated after surgery.
    Results: Of the fourteen patients, three had distal ureteral stricture, five had ureteropelvic junction obstruction, four presented duplicate kidney and ureter, one had a giant ureter, and one presented an ipsilateral native ureteral tumor after renal transplantation. The surgeries in all patients were successful, with no conversion to open surgery. In addition, no injury to the surrounding organs, anastomotic stenosis or leakage, or ICG injection-related side effects were detected. Imaging at 3 months post-operatively revealed improved renal functions compared to those before the operation. No tumor recurrence or metastasis was observed in patient 14.
    Conclusion: Fluorescence imaging compensating for the inadequacy of tactile feedback in the surgical operating system has advantages in identifying the ureter, determining the site of ureteral stricture, and protecting the blood flow for the ureter.
    Language English
    Publishing date 2023-03-02
    Publishing country Switzerland
    Document type Case Reports
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm12051980
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Network pharmacological analysis to reveal the mechanism governing the effect of Qin Xi Tong on osteoarthritis and rheumatoid arthritis.

    Lv, Yanyan / Zhang, Jie / Li, Chao / Wang, Li / Lei, Lei / Huang, Xiaoqiang

    Clinical rheumatology

    2023  Volume 42, Issue 8, Page(s) 2209–2222

    Abstract: Introduction: Qin Xi Tong (QXT), produced by water extracts of Caulis Sinomenii, is clinically ...

    Abstract Introduction: Qin Xi Tong (QXT), produced by water extracts of Caulis Sinomenii, is clinically effective in the therapy of rheumatoid arthritis (RA). It is also a complementary agent for osteoarthritis (OA). This study aimed to screen the candidate targets and identify the potential mechanisms of QXT against RA and OA.
    Method: The active ingredients contained in QXT were queried from the TCMSP database. Their predicted targets were obtained through web-based databases, including TCMSP, BATMAN-TCM, CTD, and PharmMapper. The OA and RA targets were collected from the Genecards database and the GSE55235 dataset. Based on the DAVID database, GO and KEGG enrichment analyses of disease-drug common targets predicted potential signaling pathways for QXT. In addition, core targets were identified by mapping component-target-disease interaction networks with Cytoscape 3.9.1 and STRING. The Swissdock and Pymol tools further validate the predicted results.
    Results: A total of 161 genes were put forward as potential targets for treating RA and OA. These genes might be involved in joint inflammation, including the IL-17 signaling pathway, MAPK signaling pathway, and TNF signaling pathway. They also regulated the progression of joint injuries, such as apoptosis, Th17 cell differentiation, and osteoclast differentiation. In addition, we identified 12 core targets of QXT. Molecular docking results showed that QXT has a high affinity with these core targets.
    Conclusions: This study reveals the mechanism governing the effect of QXT on RA and OA, predicts the direct target, and provides new ideas for clinical treatment. Key Points • Our study reveals the underlying mechanism of QXT in the treatment of RA and OA. • Further research into the effects of compounds in QXT alone would be of interest.
    MeSH term(s) Humans ; Molecular Docking Simulation ; Osteoarthritis/drug therapy ; Arthritis, Rheumatoid/drug therapy ; Apoptosis ; Cell Differentiation ; Drugs, Chinese Herbal/pharmacology ; Drugs, Chinese Herbal/therapeutic use ; Medicine, Chinese Traditional
    Chemical Substances Drugs, Chinese Herbal
    Language English
    Publishing date 2023-05-10
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 604755-5
    ISSN 1434-9949 ; 0770-3198
    ISSN (online) 1434-9949
    ISSN 0770-3198
    DOI 10.1007/s10067-023-06625-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Book ; Online: Tests of $CP$ symmetry in the entangled $\Xi^0-\bar{\Xi}^0$ Pairs

    BESIII Collaboration / Ablikim, M. / Achasov, M. N. / Adlarson, P. / Ai, X. C. / Aliberti, R. / Amoroso, A. / An, M. R. / An, Q. / Bai, Y. / Bakina, O. / Balossino, I. / Ban, Y. / Batozskaya, V. / Begzsuren, K. / Berger, N. / Berlowski, M. / Bertani, M. / Bettoni, D. /
    Bianchi, F. / Bianco, E. / Bortone, A. / Boyko, I. / Briere, R. A. / Brueggemann, A. / Cai, H. / Cai, X. / Calcaterra, A. / Cao, G. F. / Cao, N. / Cetin, S. A. / Chang, J. F. / Chang, T. T. / Chang, W. L. / Che, G. R. / Chelkov, G. / Chen, C. / Chen, Chao / Chen, G. / Chen, H. S. / Chen, M. L. / Chen, S. J. / Chen, S. M. / Chen, T. / Chen, X. R. / Chen, X. T. / Chen, Y. B. / Chen, Y. Q. / Chen, Z. J. / Cheng, W. S. / Choi, S. K. / Chu, X. / Cibinetto, G. / Coen, S. C. / Cossio, F. / Cui, J. J. / Dai, H. L. / Dai, J. P. / Dbeyssi, A. / de Boer, R. E. / Dedovich, D. / Deng, Z. Y. / Denig, A. / Denysenko, I. / Destefanis, M. / De Mori, F. / Ding, B. / Ding, X. X. / Ding, Y. / Dong, J. / Dong, L. Y. / Dong, M. Y. / Dong, X. / Du, M. C. / Du, S. X. / Duan, Z. H. / Egorov, P. / Fan, Y. L. / Fang, J. / Fang, S. S. / Fang, W. X. / Fang, Y. / Farinelli, R. / Fava, L. / Feldbauer, F. / Felici, G. / Feng, C. Q. / Feng, J. H. / Fischer, K / Fritsch, M. / Fritzsch, C. / Fu, C. D. / Fu, J. L. / Fu, Y. W. / Gao, H. / Gao, Y. N. / Gao, Yang / Garbolino, S. / Garzia, I. / Ge, P. T. / Ge, Z. W. / Geng, C. / Gersabeck, E. M. / Gilman, A / Goetzen, K. / Gong, L. / Gong, W. X. / Gradl, W. / Gramigna, S. / Greco, M. / Gu, M. H. / Gu, Y. T. / Guan, C. Y / Guan, Z. L. / Guo, A. Q. / Guo, L. B. / Guo, M. J. / Guo, R. P. / Guo, Y. P. / Guskov, A. / Han, T. T. / Han, W. Y. / Hao, X. Q. / Harris, F. A. / He, K. K. / He, K. L. / Heinsius, F. H. H. / Heinz, C. H. / Heng, Y. K. / Herold, C. / Holtmann, T. / Hong, P. C. / Hou, G. Y. / Hou, X. T. / Hou, Y. R. / Hou, Z. L. / Hu, H. M. / Hu, J. F. / Hu, T. / Hu, Y. / Huang, G. S. / Huang, K. X. / Huang, L. Q. / Huang, X. T. / Huang, Y. P. / Hussain, T. / Hüsken, N / Imoehl, W. / Irshad, M. / Jackson, J. / Jaeger, S. / Janchiv, S. / Jeong, J. H. / Ji, Q. / Ji, Q. P. / Ji, X. B. / Ji, X. L. / Ji, Y. Y. / Jia, X. Q. / Jia, Z. K. / Jiang, P. C. / Jiang, S. S. / Jiang, T. J. / Jiang, X. S. / Jiang, Y. / Jiao, J. B. / Jiao, Z. / Jin, S. / Jin, Y. / Jing, M. Q. / Johansson, T. / K., X. / Kabana, S. / Kalantar-Nayestanaki, N. / Kang, X. L. / Kang, X. S. / Kappert, R. / Kavatsyuk, M. / Ke, B. C. / Khoukaz, A. / Kiuchi, R. / Kliemt, R. / Kolcu, O. B. / Kopf, B. / Kuessner, M. K. / Kupsc, A. / Kühn, W. / Lane, J. J. / Larin, P. / Lavania, A. / Lavezzi, L. / Lei, T. T. / Lei, Z. H. / Leithoff, H. / Lellmann, M. / Lenz, T. / Li, C. / Li, C. H. / Li, Cheng / Li, D. M. / Li, F. / Li, G. / Li, H. / Li, H. B. / Li, H. J. / Li, H. N. / Li, Hui / Li, J. R. / Li, J. S. / Li, J. W. / Li, K. L. / Li, Ke / Li, L. J / Li, L. K. / Li, Lei / Li, M. H. / Li, P. R. / Li, Q. X. / Li, S. X. / Li, T. / Li, W. D. / Li, W. G. / Li, X. H. / Li, X. L. / Li, Xiaoyu / Li, Y. G. / Li, Z. J. / Li, Z. X. / Liang, C. / Liang, H. / Liang, Y. F. / Liang, Y. T. / Liao, G. R. / Liao, L. Z. / Libby, J. / Limphirat, A. / Lin, D. X. / Lin, T. / Liu, B. J. / Liu, B. X. / Liu, C. / Liu, C. X. / Liu, F. H. / Liu, Fang / Liu, Feng / Liu, G. M. / Liu, H. / Liu, H. B. / Liu, H. M. / Liu, Huanhuan / Liu, Huihui / Liu, J. B. / Liu, J. L. / Liu, J. Y. / Liu, K. / Liu, K. Y. / Liu, Ke / Liu, L. / Liu, L. C. / Liu, Lu / Liu, M. H. / Liu, P. L. / Liu, Q. / Liu, S. B. / Liu, T. / Liu, W. K. / Liu, W. M. / Liu, X. / Liu, Y. / Liu, Y. B. / Liu, Z. A. / Liu, Z. Q. / Lou, X. C. / Lu, F. X. / Lu, H. J. / Lu, J. G. / Lu, X. L. / Lu, Y. / Lu, Y. P. / Lu, Z. H. / Luo, C. L. / Luo, M. X. / Luo, T. / Luo, X. L. / Lyu, X. R. / Lyu, Y. F. / Ma, F. C. / Ma, H. L. / Ma, J. L. / Ma, L. L. / Ma, M. M. / Ma, Q. M. / Ma, R. Q. / Ma, R. T. / Ma, X. Y. / Ma, Y. / Ma, Y. M. / Maas, F. E. / Maggiora, M. / Malde, S. / Malik, Q. A. / Mangoni, A. / Mao, Y. J. / Mao, Z. P. / Marcello, S. / Meng, Z. X. / Messchendorp, J. G. / Mezzadri, G. / Miao, H. / Min, T. J. / Mitchell, R. E. / Mo, X. H. / Muchnoi, N. Yu. / Nefedov, Y. / Nerling, F. / Nikolaev, I. B. / Ning, Z. / Nisar, S. / Niu, Y. / Olsen, S. L. / Ouyang, Q. / Pacetti, S. / Pan, X. / Pan, Y. / Pathak, A. / Patteri, P. / Pei, Y. P. / Pelizaeus, M. / Peng, H. P. / Peters, K. / Ping, J. L. / Ping, R. G. / Plura, S. / Pogodin, S. / Prasad, V. / Qi, F. Z. / Qi, H. / Qi, H. R. / Qi, M. / Qi, T. Y. / Qian, S. / Qian, W. B. / Qiao, C. F. / Qin, J. J. / Qin, L. Q. / Qin, X. P. / Qin, X. S. / Qin, Z. H. / Qiu, J. F. / Qu, S. Q. / Redmer, C. F. / Ren, K. J. / Rivetti, A. / Rodin, V. / Rolo, M. / Rong, G. / Rosner, Ch. / Ruan, S. N. / Salone, N. / Sarantsev, A. / Schelhaas, Y. / Schoenning, K. / Scodeggio, M. / Shan, K. Y. / Shan, W. / Shan, X. Y. / Shangguan, J. F. / Shao, L. G. / Shao, M. / Shen, C. P. / Shen, H. F. / Shen, W. H. / Shen, X. Y. / Shi, B. A. / Shi, H. C. / Shi, J. L. / Shi, J. Y. / Shi, Q. Q. / Shi, R. S. / Shi, X. / Song, J. J. / Song, T. Z. / Song, W. M. / Song, Y. J. / Song, Y. X. / Sosio, S. / Spataro, S. / Stieler, F. / Su, Y. J. / Sun, G. B. / Sun, G. X. / Sun, H. / Sun, H. K. / Sun, J. F. / Sun, K. / Sun, L. / Sun, S. S. / Sun, T. / Sun, W. Y. / Sun, Y. / Sun, Y. J. / Sun, Y. Z. / Sun, Z. T. / Tan, Y. X. / Tang, C. J. / Tang, G. Y. / Tang, J. / Tang, Y. A. / Tao, L. Y / Tao, Q. T. / Tat, M. / Teng, J. X. / Thoren, V. / Tian, W. H. / Tian, Y. / Tian, Z. F. / Uman, I. / Wang, S. J. / Wang, B. / Wang, B. L. / Wang, Bo / Wang, C. W. / Wang, D. Y. / Wang, F. / Wang, H. J. / Wang, H. P. / Wang, J. P. / Wang, K. / Wang, L. L. / Wang, M. / Wang, Meng / Wang, S. / Wang, T. / Wang, T. J. / Wang, W. / Wang, W. P. / Wang, X. / Wang, X. F. / Wang, X. J. / Wang, X. L. / Wang, Y. / Wang, Y. D. / Wang, Y. F. / Wang, Y. H. / Wang, Y. N. / Wang, Y. Q. / Wang, Yaqian / Wang, Yi / Wang, Z. / Wang, Z. L. / Wang, Z. Y. / Wang, Ziyi / Wei, D. / Wei, D. H. / Weidner, F. / Wen, S. P. / Wenzel, C. W. / Wiedner, U. W. / Wilkinson, G. / Wolke, M. / Wollenberg, L. / Wu, C. / Wu, J. F. / Wu, L. H. / Wu, L. J. / Wu, X. / Wu, X. H. / Wu, Y. / Wu, Y. J. / Wu, Z. / Xia, L. / Xian, X. M. / Xiang, T. / Xiao, D. / Xiao, G. Y. / Xiao, H. / Xiao, S. Y. / Xiao, Y. L. / Xiao, Z. J. / Xie, C. / Xie, X. H. / Xie, Y. / Xie, Y. G. / Xie, Y. H. / Xie, Z. P. / Xing, T. Y. / Xu, C. F. / Xu, C. J. / Xu, G. F. / Xu, H. Y. / Xu, Q. J. / Xu, Q. N. / Xu, W. / Xu, W. L. / Xu, X. P. / Xu, Y. C. / Xu, Z. P. / Xu, Z. S. / Yan, F. / Yan, L. / Yan, W. B. / Yan, W. C. / Yan, X. Q. / Yang, H. J. / Yang, H. L. / Yang, H. X. / Yang, Tao / Yang, Y. / Yang, Y. F. / Yang, Y. X. / Yang, Yifan / Yang, Z. W. / Yao, Z. P. / Ye, M. / Ye, M. H. / Yin, J. H. / You, Z. Y. / Yu, B. X. / Yu, C. X. / Yu, G. / Yu, J. S. / Yu, T. / Yu, X. D. / Yuan, C. Z. / Yuan, L. / Yuan, S. C. / Yuan, X. Q. / Yuan, Y. / Yuan, Z. Y. / Yue, C. X. / Zafar, A. A. / Zeng, F. R. / Zeng, X. / Zeng, Y. / Zeng, Y. J. / Zhai, X. Y. / Zhai, Y. C. / Zhan, Y. H. / Zhang, A. Q. / Zhang, B. L. / Zhang, B. X. / Zhang, D. H. / Zhang, G. Y. / Zhang, H. / Zhang, H. H. / Zhang, H. Q. / Zhang, H. Y. / Zhang, J. J. / Zhang, J. L. / Zhang, J. Q. / Zhang, J. W. / Zhang, J. X. / Zhang, J. Y. / Zhang, J. Z. / Zhang, Jianyu / Zhang, Jiawei / Zhang, L. M. / Zhang, L. Q. / Zhang, Lei / Zhang, P. / Zhang, Q. Y. / Zhang, Shuihan / Zhang, Shulei / Zhang, X. D. / Zhang, X. M. / Zhang, X. Y. / Zhang, Y. / Zhang, Y. T. / Zhang, Y. H. / Zhang, Yan / Zhang, Yao / Zhang, Z. H. / Zhang, Z. L. / Zhang, Z. Y. / Zhao, G. / Zhao, J. / Zhao, J. Y. / Zhao, J. Z. / Zhao, Lei / Zhao, Ling / Zhao, M. G. / Zhao, S. J. / Zhao, Y. B. / Zhao, Y. X. / Zhao, Z. G. / Zhemchugov, A. / Zheng, B. / Zheng, J. P. / Zheng, W. J. / Zheng, Y. H. / Zhong, B. / Zhong, X. / Zhou, H. / Zhou, L. P. / Zhou, X. / Zhou, X. K. / Zhou, X. R. / Zhou, X. Y. / Zhou, Y. Z. / Zhu, J. / Zhu, K. / Zhu, K. J. / Zhu, L. / Zhu, L. X. / Zhu, S. H. / Zhu, S. Q. / Zhu, T. J. / Zhu, W. J. / Zhu, Y. C. / Zhu, Z. A. / Zou, J. H. / Zu, J.

    2023  

    Abstract: The $J/\psi \to \Xi^0 \bar{\Xi}^{0}$ process and subsequent decays are investigated using $(10087 ... of $\Xi^0$ and $\bar{\Xi}^0$ are measured with greatly improved precision over previous measurements to be ... alpha_{\Xi} = -0.3750 \pm 0.0034 \pm 0.0016$, $\bar{\alpha}_{\Xi} = 0.3790 \pm 0.0034 \pm 0.0021$, $\phi ...

    Abstract The $J/\psi \to \Xi^0 \bar{\Xi}^{0}$ process and subsequent decays are investigated using $(10087 \pm 44)\times 10^6$ $J/\psi$ events collected at the BESIII experiment. The decay parameters of $\Xi^0$ and $\bar{\Xi}^0$ are measured with greatly improved precision over previous measurements to be $\alpha_{\Xi} = -0.3750 \pm 0.0034 \pm 0.0016$, $\bar{\alpha}_{\Xi} = 0.3790 \pm 0.0034 \pm 0.0021$, $\phi_{\Xi} = 0.0051 \pm 0.0096 \pm 0.0018$~rad, $\bar{\phi}_{\Xi} = -0.0053 \pm 0.0097 \pm 0.0019$~rad, where the first and the second uncertainties are statistical and systematic, respectively. From these measurements, precise $CP$ symmetry tests in $\Xi^0$ decay are performed, and $A^{\Xi}_{CP} = (-5.4 \pm 6.5 \pm 3.1) \times 10^{-3}$ and $\Delta\phi^{\Xi}_{CP} = (-0.1 \pm 6.9 \pm 0.9) \times 10^{-3}$~rad are consistent with $CP$ conservation. The sequential decay also enables a separation of weak and strong phase differences, which are found for the first time to be $\xi_{P}-\xi_{S} = (0.0 \pm 1.7 \pm 0.2) \times 10^{-2}$~rad and $\delta_{P}-\delta_{S} = (-1.3 \pm 1.7 \pm 0.4)\times 10^{-2}$~rad, respectively. In addition, we measure the $\Lambda$ decay parameters and test $CP$ symmetry in $\Lambda$ decays.
    Keywords High Energy Physics - Experiment
    Subject code 612
    Publishing date 2023-05-16
    Publishing country us
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Global epidemiology of factor XI deficiency: A targeted review of the literature and foundation reports.

    Zhang, Xinruo / Lewandowska, Magdalena / Aldridge, Molly / Iglay, Kristy / Wolford, Eric / Shapiro, Amy

    Haemophilia : the official journal of the World Federation of Hemophilia

    2022  Volume 29, Issue 2, Page(s) 423–434

    Abstract: Introduction: Hereditary factor XI (FXI) deficiency is a rare coagulation disorder that may result ...

    Abstract Introduction: Hereditary factor XI (FXI) deficiency is a rare coagulation disorder that may result in excessive bleeding requiring intervention to restore haemostasis.
    Aim: The aim of this review was to report the current knowledge of the worldwide incidence and prevalence of FXI deficiency.
    Methods: A targeted PubMed search using terms related to FXI deficiency was conducted to identify studies published from April 2002 through April 2022. A manual search supplemented the electronic search. Studies were eligible for data abstraction if they reported population-based incidence proportions/rates or prevalence proportions for FXI deficiency.
    Results: The electronic and manual searches returned 253 publications. After applying exclusion criteria, seven publications were included in the analysis, including a global report from the World Federation of Haemophilia (WFH). Six publications provided information on the prevalence of FXI deficiency that included 74 countries and regions. The estimated prevalence of FXI in the WFH report ranged from 0/100,000 in several countries to 55.85/100,000 individuals in the United Kingdom. Prevalence estimates in the PubMed findings ranged from .1 to 246.2/1,000,000 inhabitants with varying methods of case identification and time periods of analysis. One study estimated the incidence of FXI deficiency in Yecla, Spain at 2% of blood donors and .09% of hospital inpatients/outpatients with activated partial thromboplastin time (aPTT) tests.
    Conclusion: FXI deficiency is rare across the world, but additional steps could be taken to improve incidence and prevalence estimation, for example, development of a consistent FXI deficiency definition and incorporating genetic testing into a clinical routine to better identify and characterise cases.
    MeSH term(s) Humans ; Blood Coagulation ; Factor XI/genetics ; Factor XI Deficiency/epidemiology ; Factor XI Deficiency/genetics ; Hemorrhage ; Partial Thromboplastin Time ; Internationality
    Chemical Substances Factor XI (9013-55-2)
    Language English
    Publishing date 2022-11-11
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1229713-6
    ISSN 1365-2516 ; 1351-8216 ; 1355-0691
    ISSN (online) 1365-2516
    ISSN 1351-8216 ; 1355-0691
    DOI 10.1111/hae.14687
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Contribution to the knowledge of Chinese Gryllacrididae (Orthoptera) XI: Three new species of Homogryllacris from Yunnan Province.

    Lu, Xiangyi / Zhang, Qianwen / Bian, Xun

    Zootaxa

    2022  Volume 5200, Issue 3, Page(s) 281–290

    Abstract: This paper reports three new micropterous species of Homogryllacris from Yunnan Province. And we supplement the additional description for Homogryllacris anelytra Shi, Guo & Bian, 2012 and Homogryllacris bilobus (Bey-Bienko, 1957). All examined specimens ...

    Abstract This paper reports three new micropterous species of Homogryllacris from Yunnan Province. And we supplement the additional description for Homogryllacris anelytra Shi, Guo & Bian, 2012 and Homogryllacris bilobus (Bey-Bienko, 1957). All examined specimens are deposited in Guangxi Normal University.
    MeSH term(s) Animals ; Animal Distribution ; Animal Structures ; Body Size ; China ; Organ Size ; Orthoptera
    Language English
    Publishing date 2022-10-28
    Publishing country New Zealand
    Document type Journal Article
    ISSN 1175-5334
    ISSN (online) 1175-5334
    DOI 10.11646/zootaxa.5200.3.6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Associations between coagulation factor XII, coagulation factor XI, and stability of venous thromboembolism: A case-control study.

    Meng, Yan / Li, You / Ye, Yan-Jun / Ma, Qiang / Zhang, Jun-Bo / Qin, Hao / Deng, Yang-Yang / Tian, Hong-Yan

    World journal of clinical cases

    2022  Volume 10, Issue 9, Page(s) 2700–2709

    Abstract: ... plasma antigen levels of factor XII (FXII:Ag) and factor XI (FXI:Ag) with the stability of DVT ...

    Abstract Background: Pulmonary embolism (PE) is a fatal clinical syndrome that is generally caused by an embolus from unstable deep venous thrombosis (DVT). However, clinical and biochemical factors that are related to the stability of DVT are not fully understood.
    Aim: To evaluate the relationships between plasma antigen levels of factor XII (FXII:Ag) and factor XI (FXI:Ag) with the stability of DVT.
    Methods: Patients with DVT and no PE, DVT and PE, and controls with no DVT or PE that matched for age, gender, and comorbidities were included in this study. FXII:Ag and FXI:Ag in peripheral venous blood were measured using enzyme-linked immunosorbent assays.
    Results: Using the 95
    Conclusion: Higher plasma FXI:Ag might be a marker for unstable DVT, which might be associated with PE in these patients.
    Language English
    Publishing date 2022-01-16
    Publishing country United States
    Document type Journal Article
    ISSN 2307-8960
    ISSN 2307-8960
    DOI 10.12998/wjcc.v10.i9.2700
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Ta-Xi-San Suppresses Atopic Dermatitis Involved in Multitarget Mechanism Using Experimental and Network Pharmacology Analysis.

    Zhi, Wenbing / Li, Chun / Zhang, Hong / Zhao, Yiding / Zong, Shiyu / Liu, Qiqi / Zhou, Jie / Wang, Chunliu / Sun, Tingting / Liu, Yang / Li, Ye

    Evidence-based complementary and alternative medicine : eCAM

    2022  Volume 2022, Page(s) 8441938

    Abstract: ... worldwide. Ta-Xi-San (TXS) is a Chinese herbal formula usually used for atopic dermatitis ...

    Abstract Atopic dermatitis (AD) is a relapsing and chronic skin inflammation with a common incidence worldwide. Ta-Xi-San (TXS) is a Chinese herbal formula usually used for atopic dermatitis in clinic; however, its active compounds and mechanisms of action are still unclear. Our study was designed to reveal the pharmacological activities, the active compounds, and the pharmacological mechanisms of TXS for atopic dermatitis. Mice were induced by 2,4-dinitrocluorobenzene (DNCB) to build atopic dermatitis model. The pathological evaluation, enzyme-linked immunosorbent assay (ELISA), and hematoxylin and eosin (H&E) assay were performed. The UPLC-Q-Exactive-MS
    Language English
    Publishing date 2022-05-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2171158-6
    ISSN 1741-4288 ; 1741-427X
    ISSN (online) 1741-4288
    ISSN 1741-427X
    DOI 10.1155/2022/8441938
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Evaluation of industrial development quality and analysis of influencing factors in Xi’an, China

    Zhang, Yi / Huang, Guangqiu

    Environ Sci Pollut Res. 2022 Nov., v. 29, no. 52 p.79388-79412

    2022  

    Abstract: ... system theory. The IDQ in Xi’an from 2004 to 2019 was evaluated, and the influencing mechanisms of each IDQ ... interpretive structural modeling (ISM) approach. The results show that the IDQ in Xi’an is on the rise ...

    Abstract Industry is the lifeblood of the national economy, and it is the inevitable course of sustainability for China to promote the high-quality development of industry. A theoretical framework of industrial development quality (IDQ) was constructed, and 32 influencing factors were selected based on complex system theory. The IDQ in Xi’an from 2004 to 2019 was evaluated, and the influencing mechanisms of each IDQ factor were analyzed through an integrated maximum generalized information entropy (MGIE)-self-organizing feature mapping (SOFM) neural network-decision-making trial and evaluation laboratory (DEMATEL)-interpretive structural modeling (ISM) approach. The results show that the IDQ in Xi’an is on the rise, but the development of internal subsystems is uneven, with the technology subsystem contributing the most and the social subsystem contributing the least. There is a multi-layer hierarchical structure among the influencing factors of IDQ, and the multi-layer structure model can be divided into 10 layers. The first layer is the investment intensity of industrial pollution control, which is the most direct factor that affects IDQ. The tenth layer is the industrial wastewater discharge intensity, industrial waste gas emission intensity, water consumption per unit of industrial added value, highway density, and energy consumption per unit of industrial added value, which are the root factors affecting IDQ. This study can provide a theoretical basis and reference for the promotion of high-quality industrial development.
    Keywords emissions factor ; energy ; entropy ; industrial wastes ; industrial wastewater ; industrialization ; industry ; models ; pollution control ; China
    Language English
    Dates of publication 2022-11
    Size p. 79388-79412.
    Publishing place Springer Berlin Heidelberg
    Document type Article ; Online
    ZDB-ID 1178791-0
    ISSN 1614-7499 ; 0944-1344
    ISSN (online) 1614-7499
    ISSN 0944-1344
    DOI 10.1007/s11356-022-21335-2
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top